Epidemiology of respiratory syncytial virus in various regions within North Carolina during multiple seasons
- PMID: 19256181
- PMCID: PMC5482212
Epidemiology of respiratory syncytial virus in various regions within North Carolina during multiple seasons
Abstract
Background: The Centers for Disease Control and Prevention (CDC) monitors the occurrence of respiratory syncytial virus (RSV) in the United States and has historically reported on activity at the regional level. Prior to the 2007-2008 RSVseason, the CDC did not report seasonal RSV data for cities within North Carolina or for the state. The purpose of the present study is to characterize RSV seasonal activity within North Carolina and to determine the appropriate months in which at-risk children should receive prophylaxis.
Methods: We prospectively collected RSV test data monthly over three seasons (fall through spring), from September 2003 through July 2006, from a diverse group of hospitals and a community pediatric practice located within five regions throughout North Carolina.
Results: Approximately 14,000 laboratory tests, including 23.7% that were RSV positive, were evaluated over the three seasons, and RSV was detected within the state during all but three months of the study. Seasonal variation in the onset (October-November) of RSV activity and duration (six to seven months) of the RSV season according to the specified definition of seasonality was noted yearly within individual regions and among regions. On average over the study period, the greatest percentage of positive tests (33.8%) statewide occurred during January.
Conclusions: Our data suggest the RSV season in North Carolina is longer than the national average, and RSV epidemics persist during months that fall outside of those in which RSV prophylaxis is given to high-risk children. Guidelines on the administration of RSV prophylaxis should ideally be based on results of local RSV test data.
Figures
Similar articles
-
Respiratory syncytial virus: seasonal data for regions of Florida and implications for palivizumab.South Med J. 2007 Jul;100(7):669-76. doi: 10.1097/SMJ.0b013e318048589e. South Med J. 2007. PMID: 17639745
-
Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage.Pediatr Infect Dis J. 2003 Feb;22(2 Suppl):S46-54. doi: 10.1097/01.inf.0000053885.34703.84. Pediatr Infect Dis J. 2003. PMID: 12671452
-
Evaluation of a novel web-based prior approval application for palivizumab prophylaxis of respiratory syncytial virus in a state Medicaid program.J Manag Care Pharm. 2013 Mar;19(2):115-24. doi: 10.18553/jmcp.2013.19.2.115. J Manag Care Pharm. 2013. PMID: 23461427 Free PMC article.
-
Respiratory syncytial virus seasonality, transmission zones, and implications for seasonal prevention strategy in China: a systematic analysis.Lancet Glob Health. 2024 Jun;12(6):e1005-e1016. doi: 10.1016/S2214-109X(24)00090-1. Epub 2024 Apr 23. Lancet Glob Health. 2024. PMID: 38670132
-
Palivizumab and the prevention of respiratory syncytial virus illness in pediatric patients with congenital heart disease.Expert Opin Biol Ther. 2007 Sep;7(9):1471-80. doi: 10.1517/14712598.7.9.1471. Expert Opin Biol Ther. 2007. PMID: 17727335 Review.
Cited by
-
Assessment of the Effects of Active Immunisation against Respiratory Syncytial Virus (RSV) using Decision-Analytic Models: A Systematic Review with a Focus on Vaccination Strategies, Modelling Methods and Input Data.Pharmacoeconomics. 2021 Mar;39(3):287-315. doi: 10.1007/s40273-020-00991-7. Epub 2021 Jan 19. Pharmacoeconomics. 2021. PMID: 33462760 Free PMC article.
-
Epidemiology of respiratory syncytial virus infection in preterm infants.Open Microbiol J. 2011;5:135-43. doi: 10.2174/1874285801105010135. Epub 2011 Dec 30. Open Microbiol J. 2011. PMID: 22262986 Free PMC article.
-
Understanding the local-level variations in seasonality of human respiratory syncytial virus infection: a systematic analysis.BMC Med. 2025 Jan 29;23(1):55. doi: 10.1186/s12916-025-03888-4. BMC Med. 2025. PMID: 39881360 Free PMC article.
References
-
- Shay DK, Holman RC, Newman RD, et al. Bronchiolitis-associated hospitalizations among US children, 1980–1986. JAMA. 1999;282:1440–1446. - PubMed
-
- Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr. 2003;143:S127–S132. - PubMed
-
- McLaurin K, Leader S. Growing impact of RSV hospitalizations among infants in the US, 1997–2002. Paper presented at Pediatric Academic Societies’ Meeting; May 2005; Washington, DC.
-
- Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child. 1986;140:543–546. - PubMed
-
- American Academy of Pediatrics. Respiratory Syncytial Virus. In: Pickering KL, editor. Redbook: 2006 Report of the Committee on Infectious Diseases. 27. Elk Grove Village: American Academy of Pediatrics; 2006. pp. 560–566.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical